After three consecutive years of growth, total new premium for individual life combination products dropped 2% to $4.3 billion in 2018, according to LIMRA’s 2018 Individual Life Combination Products ...

Packaging Extra Effort: Packaging for Combination Products Producing a suitable package for a combination product requires device companies to understand the regulations, materials, and processes ...

The success of Boston Scientific's Taxus drug-eluting stent helped boost combination products' popularity. However, the regulatory requirements for such products are strict. Who Will Be the Lead ...

WINDSOR, Conn., Aug. 9, 2022 — Total new premium for individual life combination products increased 22% to $4.3 billion, compared with prior year results, and down slightly from the $4.8 billion in ...

Developing a drug delivery device system (combination product) adds a layer of complexity to your pharmaceutical program that many companies underestimate until it's too late. Success depends not just ...

Maetrics, a leading international life sciences regulatory and compliance consultancy, has launched a new whitepaper on the adaptations and additions to the EU Medical Device Regulation (MDR) ...

A new combination product comprising the triptan rizatriptan and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam has shown promising results in the treatment of migraine. In the phase 3 ...

Veteran leader in drug-device development, regulatory strategy, and global standards partners with EdgeOne to strengthen expertise as combination product complexity grows EdgeOne Medical, an ...